These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22275155)

  • 1. BMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formation.
    Wang L; Park P; Zhang H; La Marca F; Claeson A; Than K; Rahman S; Lin CY
    Int J Cancer; 2012 Oct; 131(8):1941-50. PubMed ID: 22275155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral naftopidil suppresses human renal-cell carcinoma by inducing G(1) cell-cycle arrest in tumor and vascular endothelial cells.
    Iwamoto Y; Ishii K; Sasaki T; Kato M; Kanda H; Yamada Y; Arima K; Shiraishi T; Sugimura Y
    Cancer Prev Res (Phila); 2013 Sep; 6(9):1000-6. PubMed ID: 23901046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of bone morphogenetic protein (BMP) receptor type II correlates with insensitivity to BMP-6 in human renal cell carcinoma cells.
    Kim IY; Lee DH; Lee DK; Kim BC; Kim HT; Leach FS; Linehan WM; Morton RA; Kim SJ
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):6046-51. PubMed ID: 14676131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triiodothyronine regulates cell growth and survival in renal cell cancer.
    Czarnecka AM; Matak D; Szymanski L; Czarnecka KH; Lewicki S; Zdanowski R; Brzezianska-Lasota E; Szczylik C
    Int J Oncol; 2016 Oct; 49(4):1666-78. PubMed ID: 27632932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
    Uchida T; Gao JP; Wang C; Satoh T; Itoh I; Muramoto M; Hyodo T; Irie A; Akahoshi T; Jiang SX; Kameya T; Baba S
    Mol Urol; 2001; 5(2):71-8. PubMed ID: 11690551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastin inhibits migration and invasion of renal cell carcinoma with overexpression of metastin receptor.
    Shoji S; Tang XY; Umemura S; Itoh J; Takekoshi S; Shima M; Usui Y; Nagata Y; Uchida T; Osamura RY; Terachi T
    Eur Urol; 2009 Feb; 55(2):441-9. PubMed ID: 18395325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
    Tomari K; Kumagai T; Shimizu T; Takeda K
    Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma.
    Wakita T; Hayashi T; Nishioka J; Tamaru H; Akita N; Asanuma K; Kamada H; Gabazza EC; Ido M; Kawamura J; Suzuki K
    Int J Cancer; 2004 Feb; 108(4):516-23. PubMed ID: 14696115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of a new cell line from a renal carcinoma bone metastasis.
    Avnet S; Cenni E; Granchi D; Perut F; Amato I; Battistelli L; Brandi ML; Giunti A; Baldini N
    Anticancer Res; 2004; 24(3a):1705-11. PubMed ID: 15274344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wnt antagonist DKK1 acts as a tumor suppressor gene that induces apoptosis and inhibits proliferation in human renal cell carcinoma.
    Hirata H; Hinoda Y; Nakajima K; Kawamoto K; Kikuno N; Ueno K; Yamamura S; Zaman MS; Khatri G; Chen Y; Saini S; Majid S; Deng G; Ishii N; Dahiya R
    Int J Cancer; 2011 Apr; 128(8):1793-803. PubMed ID: 20549706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma.
    Sato A; Nagase H; Obinata D; Fujiwara K; Fukuda N; Soma M; Yamaguchi K; Kawata N; Takahashi S
    Int J Oncol; 2013 Nov; 43(5):1441-6. PubMed ID: 23969530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Src family inhibitor (PP1) potentiates tumor-suppressive effect of connexin 32 gene in renal cancer cells.
    Fujimoto E; Sato H; Nagashima Y; Negishi E; Shirai S; Fukumoto K; Hagiwara H; Hagiwara K; Ueno K; Yano T
    Life Sci; 2005 Apr; 76(23):2711-20. PubMed ID: 15792837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D3 triggers antitumor activity through targeting hedgehog signaling in human renal cell carcinoma.
    Dormoy V; Béraud C; Lindner V; Coquard C; Barthelmebs M; Brasse D; Jacqmin D; Lang H; Massfelder T
    Carcinogenesis; 2012 Nov; 33(11):2084-93. PubMed ID: 22843547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma.
    Sato H; Hagiwara H; Senba H; Fukumoto K; Nagashima Y; Yamasaki H; Ueno K; Yano T
    Mol Carcinog; 2008 Jun; 47(6):403-9. PubMed ID: 18058801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and functional influence of cellular retinoic acid-binding protein II in renal cell carcinoma.
    Goelden U; Pfoertner S; Hansen W; Toepfer T; von Knobloch R; Hofmann R; Buer J; Schrader AJ
    Urol Int; 2005; 75(3):269-76. PubMed ID: 16215318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal tumor-derived exosomes inhibit hepaCAM expression of renal carcinoma cells in a p-AKT-dependent manner.
    Jiang XL; Zhang Y; Tan B; Luo CL; Wu XH
    Neoplasma; 2014; 61(4):416-23. PubMed ID: 24645843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells.
    Miyazaki H; Watabe T; Kitamura T; Miyazono K
    Oncogene; 2004 Dec; 23(58):9326-35. PubMed ID: 15531927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells.
    Cho MC; Cho SY; Yoon CY; Lee SB; Kwak C; Kim HH; Jeong H
    PLoS One; 2015; 10(7):e0130975. PubMed ID: 26177500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.